Biomedical research generates vast amounts of data. New experimental technologies like DNA sequencing, metabolomics and proteomics drive the fast growth of available information and lead to a better understanding of the molecular organization of life.
But with big data comes a big question: How do we transform unstructured data into actionable knowledge? In the case of biomedical research, the key problem is to integrate the large pile of highly heterogenous data and use it for personalized therapies and drug development. Graph databases are an ideal way to represent biomedical knowledge and offer the necessary flexibility to keep up with scientific progress. A well-designed data model and Cypher queries can deliver in seconds what previously took days of manual analysis.
YOU MAY ALSO LIKE:
- Leonardo De Marchi's Deep Learning Fundamentals (in London on 22nd - 23rd October 2019)
- Brian Sletten's Data Science with Python Workshop (in London on 18th - 20th November 2019)
- Scala eXchange London 2019 (in London on 12th - 13th December 2019)
- Practical ML 2020 (in London on 2nd - 3rd July 2020)
- Clean Architecture using BLoC & Voyager: DI & the Widget Router (in London on 21st October 2019)
- Security in the Age of Big Data (Data Anonymisation & Encryption) (in London on 21st October 2019)
- How AI can be used to enable assisted living for the ageing population (SkillsCast recorded in October 2019)
- The importance of DataOps (SkillsCast recorded in October 2019)
Big Data in Genomics: How Neo4j helps to develop new drugs
Martin Preusse studied biochemistry at TU München and is currently finishing his PhD in bioinformatics at the Institute for Computational Biology (Helmholtz Zentrum München, Germany). He focuses on integration of heterogeneous experimental data sets to understand cellular decision-making. Next to academic research, he is working on a startup that develops data solutions for biomedical research and biotech industry.